Our data reveals AD-like inflammatory changes upon MC903-treatment, for example, the presence of Th2-associated cytokines such as IL-4, IL-5, and IL-13 and only very low levels of Th1-associated cytokines. This evidence concerns the gene IL5 and Alzheimer disease.